Mark W. Bruner
Impact in
- Virology top 5%
- HIV Research and Treatment
- Molecular Biology top 10%
- Protein purification and stability
- Fibroblast Growth Factor Research
- Viral Infectious Diseases and Gene Expression in Insects
- RNA Interference and Gene Delivery
Papers in
-
- Fibroblast Growth Factor Research 6
- Viral Infectious Diseases and Gene Expression in Insects 4
- Protein purification and stability 2
- RNA Interference and Gene Delivery 2
-
- Proteoglycans and glycosaminoglycans research 3
- Co-authors
- C. Russell Middaugh (10 shared papers)David B. Volkin (7 shared papers)Carl J. Burke (5 shared papers)James A. Ryan (3 shared papers)P.K. Tsai (6 shared papers)Marian L. Harter (3 shared papers)Gautam Sanyal (2 shared papers)Robert K. Evans (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Journal of Biological Chemistry (3 papers)Pharmaceutical Research (2 papers)Biochemistry (2 papers)Biologicals (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Mark W. Bruner
17 papers receiving 905 citations
Peers
Comparison fields: 5 of 95
- Virology 125
- Molecular Biology 729
- Infectious Diseases 172
- Cell Biology 139
- Pharmaceutical Science 32
Countries citing papers authored by Mark W. Bruner
This map shows the geographic impact of Mark W. Bruner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Bruner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Bruner more than expected).
Fields of papers citing papers by Mark W. Bruner
This network shows the impact of papers produced by Mark W. Bruner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Bruner. The network helps show where Mark W. Bruner may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark W. Bruner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 147 | |
| 2 | 1992 | 127 | |
| 3 | 1991 | 111 | |
| 4 | 2000 | 100 | |
| 5 | 1993 | 87 | |
| 6 | 1988 | 68 | |
| 7 | 2010 | 63 | |
| 8 | 2005 | 57 | |
| 9 | 1993 | 45 | |
| 10 | 1987 | 37 | |
| 11 | 1992 | 37 | |
| 12 | 1994 | 29 | |
| 13 | 1995 | 11 | |
| 14 | 1997 | 6 | |
| 15 | 1988 | 6 | |
| 16 | 2003 | 4 | |
| 17 | 1995 | 1 |
About Mark W. Bruner
Mark W. Bruner is a scholar working on Molecular Biology, Cell Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 17 papers that have together received 936 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Virus-based gene therapy research (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Peptidase Inhibition and Analysis (2 papers), Protein purification and stability (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Virology (125 citations), Molecular Biology (729 citations), Infectious Diseases (172 citations), Cell Biology (139 citations) and Pharmaceutical Science (32 citations). Mark W. Bruner has collaborated with scholars based in United States, France and Germany. Frequent co-authors include C. Russell Middaugh, David B. Volkin, Carl J. Burke, James A. Ryan, P.K. Tsai, Marian L. Harter, Gautam Sanyal, Robert K. Evans, S. J. Flint and Bei Wang. Their work appears in journals such as Journal of Pharmaceutical Sciences, Journal of Biological Chemistry, Pharmaceutical Research, Biochemistry and Biologicals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.